We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reducing Inappropriate Prescribing for Psychiatric Patients Using Nurse-led Medication Reviews

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02052505
Recruitment Status : Completed
First Posted : February 3, 2014
Last Update Posted : January 5, 2017
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to investigate the effect of nurse-led medication reviews on the frequency, type and potential severity of PIP in psychiatric patients

Condition or disease Intervention/treatment
Inappropriate Prescribing Procedure: Medication review

  Show Detailed Description

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 411 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Reducing Inappropriate Prescribing for Psychiatric Patients Using Nurse-led Medication Reviews - an Interventional Study
Study Start Date : October 2014
Primary Completion Date : June 2015
Study Completion Date : July 2015
Arms and Interventions

Arm Intervention/treatment
No Intervention: Usual care
The patients will receive the usual care when admitted. This includes an examination by a physician, a medication review and the physician will prescribe medications for the patients as well as other necessary interventions.
Experimental: Medication review
The patients will receive the usual care when admitted. This includes an examination by a physician, a medication review and the physician will prescribe medications for the patients as well as other necessary interventions. Following this (usual care) a trained nurse will perform a medication review and discuss the observations with a physician.
Procedure: Medication review
The medication review will be based on the nurses experience, clinical knowledge and predefined categories of inappropriate prescribing


Outcome Measures

Primary Outcome Measures :
  1. Estimation of potential difference in mean number of PIPs when applying nurses' observations [ Time Frame: within the first 3 days after admission ]
  2. The potential difference in patients receiving ≥ 1 PIP when applying nurses' observations [ Time Frame: within the first 3 days after admission ]

Secondary Outcome Measures :
  1. Prevalence and types of PIP where physicians responded to nurses' observations and changed medicationsintervention by a physician [ Time Frame: within the first 3 days after admission ]

Other Outcome Measures:
  1. Assessment of type and severity of identified inappropriate prescriptions [ Time Frame: up to 1 week after admission ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • admitted to one of the included psychiatric wards
  • must be over 18 years

Exclusion Criteria:

- concurrent admission to a somatic ward

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02052505


Locations
Denmark
Aalborg University Hospital Psychiatry
Aalborg, Denmark, 9000
Psychiatry, Aalborg University Hospital
Aalborg, Denmark, 9000
Sponsors and Collaborators
Aalborg University
Danish Center for Healthcare Improvement
Aalborg Universitetshospital
University College of North Jutland, The Nursing Department
Investigators
Principal Investigator: Ann L Sorensen, MHSc Aalborg University
More Information

Responsible Party: Ann Lykkegaard Sørensen, MHSc, Aalborg University
ClinicalTrials.gov Identifier: NCT02052505     History of Changes
Other Study ID Numbers: ALS01
First Posted: February 3, 2014    Key Record Dates
Last Update Posted: January 5, 2017
Last Verified: January 2017

Keywords provided by Ann Lykkegaard Sørensen, Aalborg University:
inappropriate prescribing
psychiatry
medication quality
patient safety
medication errors